Biopharmaceutical Market Report

Global Biopharmaceutical Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 09, 2022
  • PAGES：207
  • REPORT CODE：GMM865038
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Biopharmaceutical market report explains the definition, types, applications, major countries, and major players of the Biopharmaceutical market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Johnson & Johnson

    • AbbVie

    • Novartis

    • Eli Lilly

    • Roche

    • Amgen

    • Novo Nordisk

    • Pfizer

    • Sanofi-Aventis

    • Merck

    By Type:

    • Monoclonal Antibodies

    • Interferon

    • Erythropoietin

    • Insulin

    • Other

    By End-User:

    • Tumor

    • Diabetes

    • Cardiovascular

    • Hemophilia

    • Other

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Biopharmaceutical Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Biopharmaceutical Outlook to 2028- Original Forecasts

    • 2.2 Biopharmaceutical Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Biopharmaceutical Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Biopharmaceutical Market- Recent Developments

    • 6.1 Biopharmaceutical Market News and Developments

    • 6.2 Biopharmaceutical Market Deals Landscape

    7 Biopharmaceutical Raw Materials and Cost Structure Analysis

    • 7.1 Biopharmaceutical Key Raw Materials

    • 7.2 Biopharmaceutical Price Trend of Key Raw Materials

    • 7.3 Biopharmaceutical Key Suppliers of Raw Materials

    • 7.4 Biopharmaceutical Market Concentration Rate of Raw Materials

    • 7.5 Biopharmaceutical Cost Structure Analysis

      • 7.5.1 Biopharmaceutical Raw Materials Analysis

      • 7.5.2 Biopharmaceutical Labor Cost Analysis

      • 7.5.3 Biopharmaceutical Manufacturing Expenses Analysis

    8 Global Biopharmaceutical Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Biopharmaceutical Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Biopharmaceutical Export by Region (Top 10 Countries) (2017-2028)

    9 Global Biopharmaceutical Market Outlook by Types and Applications to 2022

    • 9.1 Global Biopharmaceutical Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Interferon Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Erythropoietin Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Insulin Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Biopharmaceutical Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Tumor Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Diabetes Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Cardiovascular Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Hemophilia Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Other Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Biopharmaceutical Market Analysis and Outlook till 2022

    • 10.1 Global Biopharmaceutical Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Biopharmaceutical Consumption (2017-2022)

      • 10.2.2 Canada Biopharmaceutical Consumption (2017-2022)

      • 10.2.3 Mexico Biopharmaceutical Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Biopharmaceutical Consumption (2017-2022)

      • 10.3.2 UK Biopharmaceutical Consumption (2017-2022)

      • 10.3.3 Spain Biopharmaceutical Consumption (2017-2022)

      • 10.3.4 Belgium Biopharmaceutical Consumption (2017-2022)

      • 10.3.5 France Biopharmaceutical Consumption (2017-2022)

      • 10.3.6 Italy Biopharmaceutical Consumption (2017-2022)

      • 10.3.7 Denmark Biopharmaceutical Consumption (2017-2022)

      • 10.3.8 Finland Biopharmaceutical Consumption (2017-2022)

      • 10.3.9 Norway Biopharmaceutical Consumption (2017-2022)

      • 10.3.10 Sweden Biopharmaceutical Consumption (2017-2022)

      • 10.3.11 Poland Biopharmaceutical Consumption (2017-2022)

      • 10.3.12 Russia Biopharmaceutical Consumption (2017-2022)

      • 10.3.13 Turkey Biopharmaceutical Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Biopharmaceutical Consumption (2017-2022)

      • 10.4.2 Japan Biopharmaceutical Consumption (2017-2022)

      • 10.4.3 India Biopharmaceutical Consumption (2017-2022)

      • 10.4.4 South Korea Biopharmaceutical Consumption (2017-2022)

      • 10.4.5 Pakistan Biopharmaceutical Consumption (2017-2022)

      • 10.4.6 Bangladesh Biopharmaceutical Consumption (2017-2022)

      • 10.4.7 Indonesia Biopharmaceutical Consumption (2017-2022)

      • 10.4.8 Thailand Biopharmaceutical Consumption (2017-2022)

      • 10.4.9 Singapore Biopharmaceutical Consumption (2017-2022)

      • 10.4.10 Malaysia Biopharmaceutical Consumption (2017-2022)

      • 10.4.11 Philippines Biopharmaceutical Consumption (2017-2022)

      • 10.4.12 Vietnam Biopharmaceutical Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Biopharmaceutical Consumption (2017-2022)

      • 10.5.2 Colombia Biopharmaceutical Consumption (2017-2022)

      • 10.5.3 Chile Biopharmaceutical Consumption (2017-2022)

      • 10.5.4 Argentina Biopharmaceutical Consumption (2017-2022)

      • 10.5.5 Venezuela Biopharmaceutical Consumption (2017-2022)

      • 10.5.6 Peru Biopharmaceutical Consumption (2017-2022)

      • 10.5.7 Puerto Rico Biopharmaceutical Consumption (2017-2022)

      • 10.5.8 Ecuador Biopharmaceutical Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Biopharmaceutical Consumption (2017-2022)

      • 10.6.2 Kuwait Biopharmaceutical Consumption (2017-2022)

      • 10.6.3 Oman Biopharmaceutical Consumption (2017-2022)

      • 10.6.4 Qatar Biopharmaceutical Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Biopharmaceutical Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Biopharmaceutical Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Biopharmaceutical Consumption (2017-2022)

      • 10.7.2 South Africa Biopharmaceutical Consumption (2017-2022)

      • 10.7.3 Egypt Biopharmaceutical Consumption (2017-2022)

      • 10.7.4 Algeria Biopharmaceutical Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Biopharmaceutical Consumption (2017-2022)

      • 10.8.2 New Zealand Biopharmaceutical Consumption (2017-2022)

    11 Global Biopharmaceutical Competitive Analysis

    • 11.1 Johnson & Johnson

      • 11.1.1 Johnson & Johnson Company Details

      • 11.1.2 Johnson & Johnson Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Johnson & Johnson Biopharmaceutical Main Business and Markets Served

      • 11.1.4 Johnson & Johnson Biopharmaceutical Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 AbbVie

      • 11.2.1 AbbVie Company Details

      • 11.2.2 AbbVie Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 AbbVie Biopharmaceutical Main Business and Markets Served

      • 11.2.4 AbbVie Biopharmaceutical Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Novartis

      • 11.3.1 Novartis Company Details

      • 11.3.2 Novartis Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Novartis Biopharmaceutical Main Business and Markets Served

      • 11.3.4 Novartis Biopharmaceutical Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Eli Lilly

      • 11.4.1 Eli Lilly Company Details

      • 11.4.2 Eli Lilly Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Eli Lilly Biopharmaceutical Main Business and Markets Served

      • 11.4.4 Eli Lilly Biopharmaceutical Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Roche

      • 11.5.1 Roche Company Details

      • 11.5.2 Roche Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Roche Biopharmaceutical Main Business and Markets Served

      • 11.5.4 Roche Biopharmaceutical Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Amgen

      • 11.6.1 Amgen Company Details

      • 11.6.2 Amgen Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Amgen Biopharmaceutical Main Business and Markets Served

      • 11.6.4 Amgen Biopharmaceutical Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Novo Nordisk

      • 11.7.1 Novo Nordisk Company Details

      • 11.7.2 Novo Nordisk Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Novo Nordisk Biopharmaceutical Main Business and Markets Served

      • 11.7.4 Novo Nordisk Biopharmaceutical Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Pfizer

      • 11.8.1 Pfizer Company Details

      • 11.8.2 Pfizer Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Pfizer Biopharmaceutical Main Business and Markets Served

      • 11.8.4 Pfizer Biopharmaceutical Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Sanofi-Aventis

      • 11.9.1 Sanofi-Aventis Company Details

      • 11.9.2 Sanofi-Aventis Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Sanofi-Aventis Biopharmaceutical Main Business and Markets Served

      • 11.9.4 Sanofi-Aventis Biopharmaceutical Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Merck

      • 11.10.1 Merck Company Details

      • 11.10.2 Merck Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Merck Biopharmaceutical Main Business and Markets Served

      • 11.10.4 Merck Biopharmaceutical Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global Biopharmaceutical Market Outlook by Types and Applications to 2028

    • 12.1 Global Biopharmaceutical Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Interferon Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Insulin Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Biopharmaceutical Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Tumor Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Hemophilia Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Biopharmaceutical Market Analysis and Outlook to 2028

    • 13.1 Global Biopharmaceutical Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.2.2 Canada Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Biopharmaceutical Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.3.2 UK Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.3.3 Spain Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.3.5 France Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.3.6 Italy Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.3.8 Finland Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.3.9 Norway Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.3.11 Poland Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.3.12 Russia Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Biopharmaceutical Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.4.2 Japan Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.4.3 India Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Biopharmaceutical Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.5.3 Chile Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.5.6 Peru Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Biopharmaceutical Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.6.3 Oman Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Biopharmaceutical Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Biopharmaceutical Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Biopharmaceutical Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Biopharmaceutical Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Biopharmaceutical

    • Figure of Biopharmaceutical Picture

    • Table Global Biopharmaceutical Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Biopharmaceutical Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)

    • Figure Global Interferon Consumption and Growth Rate (2017-2022)

    • Figure Global Erythropoietin Consumption and Growth Rate (2017-2022)

    • Figure Global Insulin Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Tumor Consumption and Growth Rate (2017-2022)

    • Figure Global Diabetes Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiovascular Consumption and Growth Rate (2017-2022)

    • Figure Global Hemophilia Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Biopharmaceutical Consumption by Country (2017-2022)

    • Table North America Biopharmaceutical Consumption by Country (2017-2022)

    • Figure United States Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Canada Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Mexico Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Table Europe Biopharmaceutical Consumption by Country (2017-2022)

    • Figure Germany Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure UK Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Spain Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Belgium Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure France Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Italy Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Denmark Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Finland Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Norway Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Sweden Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Poland Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Russia Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Turkey Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Table APAC Biopharmaceutical Consumption by Country (2017-2022)

    • Figure China Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Japan Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure India Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure South Korea Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Thailand Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Singapore Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Philippines Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Table South America Biopharmaceutical Consumption by Country (2017-2022)

    • Figure Brazil Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Colombia Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Chile Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Argentina Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Peru Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Table GCC Biopharmaceutical Consumption by Country (2017-2022)

    • Figure Bahrain Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Oman Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Qatar Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Table Africa Biopharmaceutical Consumption by Country (2017-2022)

    • Figure Nigeria Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure South Africa Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Egypt Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure Algeria Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Table Oceania Biopharmaceutical Consumption by Country (2017-2022)

    • Figure Australia Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Biopharmaceutical Consumption and Growth Rate (2017-2022)

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Biopharmaceutical Main Business and Markets Served

    • Table Johnson & Johnson Biopharmaceutical Product Portfolio

    • Table AbbVie Company Details

    • Table AbbVie Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Biopharmaceutical Main Business and Markets Served

    • Table AbbVie Biopharmaceutical Product Portfolio

    • Table Novartis Company Details

    • Table Novartis Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Biopharmaceutical Main Business and Markets Served

    • Table Novartis Biopharmaceutical Product Portfolio

    • Table Eli Lilly Company Details

    • Table Eli Lilly Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Biopharmaceutical Main Business and Markets Served

    • Table Eli Lilly Biopharmaceutical Product Portfolio

    • Table Roche Company Details

    • Table Roche Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Biopharmaceutical Main Business and Markets Served

    • Table Roche Biopharmaceutical Product Portfolio

    • Table Amgen Company Details

    • Table Amgen Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Biopharmaceutical Main Business and Markets Served

    • Table Amgen Biopharmaceutical Product Portfolio

    • Table Novo Nordisk Company Details

    • Table Novo Nordisk Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk Biopharmaceutical Main Business and Markets Served

    • Table Novo Nordisk Biopharmaceutical Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Biopharmaceutical Main Business and Markets Served

    • Table Pfizer Biopharmaceutical Product Portfolio

    • Table Sanofi-Aventis Company Details

    • Table Sanofi-Aventis Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi-Aventis Biopharmaceutical Main Business and Markets Served

    • Table Sanofi-Aventis Biopharmaceutical Product Portfolio

    • Table Merck Company Details

    • Table Merck Biopharmaceutical Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Biopharmaceutical Main Business and Markets Served

    • Table Merck Biopharmaceutical Product Portfolio

    • Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Interferon Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Erythropoietin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Insulin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tumor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiovascular Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hemophilia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biopharmaceutical Consumption Forecast by Country (2022-2028)

    • Table North America Biopharmaceutical Consumption Forecast by Country (2022-2028)

    • Figure United States Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Biopharmaceutical Consumption Forecast by Country (2022-2028)

    • Figure Germany Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Biopharmaceutical Consumption Forecast by Country (2022-2028)

    • Figure China Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Biopharmaceutical Consumption Forecast by Country (2022-2028)

    • Figure Brazil Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Biopharmaceutical Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Biopharmaceutical Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Biopharmaceutical Consumption Forecast by Country (2022-2028)

    • Figure Australia Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US